Provided by Tiger Trade Technology Pte. Ltd.

Amylyx Pharmaceuticals

28.14
+0.94003.46%
Post-market: 28.00-0.1400-0.50%16:50 EDT
Volume:1.47M
Turnover:41.27M
Market Cap:3.55B
PE:-19.67
High:28.60
Open:27.32
Low:26.94
Close:27.20
52wk High:41.14
52wk Low:10.83
Shares:126.00M
Float Shares:110.00M
Volume Ratio:0.94
T/O Rate:1.34%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4309
EPS(LYR):-1.5305
ROE:-74.73%
ROA:-44.13%
PB:14.82
PE(LYR):-18.39

Loading ...

Amylyx Director George M. Milne Jr Disposes of 30,000 Common Shares Worth $830,904

Reuters
·
Oct 08

NUE Power Sharpened Focus on Canadian Energy Projects After Leadership Overhaul

TIPRANKS
·
Oct 08

What Amylyx Pharmaceuticals (AMLX)'s Phase 3 Data Presentation Means For Shareholders

Simply Wall St.
·
Oct 07

Amylyx to Present Phase 3 Lucidity Topline Data for Avexitide in Post-Bariatric Hypoglycemia at ObesityWeek 2026

Reuters
·
Oct 06

3 High Growth Stocks To Own In October 2026

Simply Wall St.
·
Oct 06

APA seals CS Energy deal for $1.3bn Brigalow peaking plant

TIPRANKS
·
Sep 30

White House proposes investing $5B in Middle East energy rebuild, WSJ says

TIPRANKS
·
Sep 22

AI Construction Group Buildots Raises $130M to Keep Data Center Rollout on Schedule

TIPRANKS
·
Sep 15

Canaan Converts Crypto Treasury Into Buybacks as August 2026 Mining Output Holds Steady

TIPRANKS
·
Sep 14

Onterris awarded contract worth over C$9M by Canadian energy infrastructure co.

TIPRANKS
·
Sep 14

Brent Crude Surges Past $102 as Escalating U.S.-Iran Conflict Drives Energy Inflation Concerns

TIPRANKS
·
Sep 10

Amylyx inks long-term manufacturing deal for avexitide

TIPRANKS
·
Sep 09

Amylyx Pharmaceuticals - Bachem and Polypeptide to be Non-Exclusive Suppliers for Amylyx - SEC Filing

THOMSON REUTERS
·
Sep 09

Amylyx Pharmaceuticals - Polypeptide Agreement Includes Fixed Volume-Based Pricing with Annual Adjustment - SEC Filing

THOMSON REUTERS
·
Sep 09

Amylyx Pharmaceuticals - Bachem Manufacturing Agreement Has Initial 5 Year Term, Auto-Renews for 3 Years, Unless Earlier Terminated with Its Terms

THOMSON REUTERS
·
Sep 09

Amylyx Pharmaceuticals - Enters Manufacturing Agreement with Bachem Americas on Sept 8, 2026 - SEC Filing

THOMSON REUTERS
·
Sep 09

Amylyx Signs Bachem Manufacturing Deal for Avexitide Supply Starting 2028

Reuters
·
Sep 09

Amylyx Pharmaceuticals to Present at Morgan Stanley Global Healthcare Conference

Reuters
·
Sep 08

Hedge Fund Giant Sets Sights on US Shale Assets After Missing Out on WildFire Deal

Deep News
·
Sep 05

Is Amylyx Pharmaceuticals (AMLX) Expensive As Phase 3 Avexitide Data Clears The Way?

Simply Wall St.
·
Sep 01